Ovsyannikova, I G
Salk, H M
Kennedy, R B
Haralambieva, I H
Zimmermann, M T
Grill, D E
Oberg, A L
Poland, G A
Article History
Received: 15 December 2015
Revised: 7 June 2016
Accepted: 9 June 2016
First Online: 18 August 2016
Competing interests
: Dr Poland is the chair of a Safety Evaluation Committee for novel investigational vaccine trials being conducted by Merck Research Laboratories. Dr Poland offers consultative advice on vaccine development to Merck & Co. Inc., CSL Biotherapies, Avianax, Dynavax, Novartis Vaccines and Therapeutics, Emergent Biosolutions, Adjuvance, Microdermis, Seqirus, NewLink, Protein Sciences, GSK Vaccines and Sanofi Pasteur. Drs Poland and Ovsyannikova hold two patents related to vaccinia and measles peptide research. These activities have been reviewed by the Mayo Clinic Conflict of Interest Review Board and are conducted in compliance with Mayo Clinic Conflict of Interest policies. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and was conducted in compliance with Mayo Clinic Conflict of Interest policies. All other authors declare no conlict of interest.
Free to read: This content has been made available to all.